US Physical Therapy appoints Myra Davis to board
U.S. Physical Therapy, Inc. (USPH) reported that its Board of Directors approved the appointment of Myra Davis as a director, effective October 1, 2026.
Rhea-AI Filing Summary
U.S. Physical Therapy, Inc. (USPH) reported that its Board of Directors approved the appointment of Myra Davis as a director, effective October 1, 2026. Davis, age 61, is Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital and has held senior IT leadership roles there since 2003.
Upon joining the Board, Davis will receive cash and equity compensation determined under the processes described in the company’s April 16, 2026 proxy statement. The company states there are no arrangements under which she was selected and no related-party transactions requiring disclosure. USPH notes it owns and/or manages 799 outpatient physical therapy clinics across 45 states.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
2 items: 5.02, 9.01
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Effective date of Board appointment: October 1, 2026
Director age: 61 years
Clinics owned and/or managed: 799 clinics
+3 more
6 metrics
Effective date of Board appointment
October 1, 2026
Date Myra Davis is scheduled to join the Board of Directors
Director age
61 years
Age of Myra Davis at the time of the appointment disclosure
Clinics owned and/or managed
799 clinics
Number of outpatient physical therapy clinics operated in the United States
States of operation
45 states
Geographic spread of U.S. Physical Therapy’s outpatient clinic operations
Year founded
1990
Founding year of U.S. Physical Therapy, Inc.
Proxy filing date referenced
April 16, 2026
Date of definitive proxy statement used to determine director compensation
Key Terms
digital transformation, industrial injury prevention, post-offer employment testing, functional capacity evaluations, +2 more
6 terms
digital transformation technical
"In this role, Ms. Davis leads enterprise technology strategy, digital transformation, innovation"
Digital transformation is the process of using digital technologies to fundamentally change how organizations operate, deliver value, and connect with customers. It often involves updating systems, automating tasks, and improving digital tools to increase efficiency and stay competitive. For investors, it signifies a company's ability to adapt to technological advances, which can impact its growth prospects and long-term success.
industrial injury prevention medical
"USPH also has an industrial injury prevention business which provides onsite services"
Measures, equipment and practices that companies use to keep workers from getting hurt on the job, such as training, safety gear, machine guards, and procedures for risky tasks. Like routine maintenance for a car, effective prevention reduces breakdowns — for investors that means lower medical and legal costs, fewer lost workdays, steadier production and less reputational or regulatory risk, all of which can protect profits and valuation.
post-offer employment testing other
"including injury prevention and rehabilitation, performance optimization, post-offer employment testing"
Post-offer employment testing is the set of checks an employer requires after making a job offer but before the new hire starts, such as drug screens, medical exams, background or fitness-for-duty assessments. Investors should care because these tests can delay or void key hires, affect operational continuity and regulatory compliance, and signal potential legal or reputational risks—think of it as a final quality control step that can change whether a promised hire actually happens.
functional capacity evaluations medical
"performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic"
Functional capacity evaluations are structured assessments that measure a person's physical and sometimes mental ability to perform specific job tasks, like lifting, standing, or concentrating. Think of it as a road test that shows whether someone can safely and effectively return to work or needs accommodations; for investors, these evaluations influence healthcare and insurance costs, benefit payments, workplace liability, and the pace at which employees can be returned to productive roles.
ergonomic assessments medical
"post-offer employment testing, functional capacity evaluations, and ergonomic assessments"
Ergonomic assessments are evaluations of workstations, tools and tasks to see how well they fit the human body and reduce strain or injury. Like tailoring a chair and desk to a person's shape, these reviews identify changes that can lower medical costs, reduce sick leave and boost productivity. Investors watch them because better ergonomics can cut liability and operating costs, improve employee retention and protect a company’s reputation.
Regulation S-K regulatory
"no related-party transactions between Ms. Davis and the Company that are reportable under Item 404(a) of Regulation S-K"
A set of U.S. Securities and Exchange Commission rules that tell public companies which narrative and qualitative details must be disclosed in filings, such as risk factors, management discussion, executive pay, legal proceedings and business description. Think of it as a standardized checklist or blueprint that ensures investors get the same types of background information from every company so they can compare risks, management quality and strategy before making investment decisions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Board change did USPH announce in this Form 8-K?
U.S. Physical Therapy, Inc. announced that its Board of Directors approved the appointment of Myra Davis as a Board member, effective October 1, 2026, adding an experienced healthcare technology executive to its governance structure.
What is Myra Davis’s current role outside USPH?
Myra Davis serves as Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital, a role she has held since 2023, after earlier serving as Chief Information Officer and other senior technology leadership roles at the same organization.
Will Myra Davis receive director compensation from USPH (symbol USPH)?
Yes. Upon joining the Board on October 1, 2026, Myra Davis will receive an annual cash retainer and annual equity grant, with amounts determined under the processes described in the company’s definitive proxy statement filed on April 16, 2026.
How large is U.S. Physical Therapy’s clinic footprint mentioned in this filing?
U.S. Physical Therapy reports that it owns and/or manages 799 outpatient physical therapy clinics in 45 states, providing orthopedic, sports-related, neurologic, and industrial injury prevention services.
Does USPH describe how Myra Davis was selected as a director?
Yes. The company states there are no arrangements or understandings between Myra Davis and any other person pursuant to which she was selected to serve as a director, indicating a standard Board appointment process.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 15, 2026
(Exact name of registrant as specified in its charter)
|
|
|
|
||
|
(State or other jurisdiction
of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant's telephone number, including area code: (713 ) 297-7000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions ( see General Instruction A.2. below):
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
Emerging growth company
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
◻
|
ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.
On September 15, 2026,
U.S. Physical Therapy Inc.’s (“Company”) Board of Directors (the “Board”) approved the appointment of Ms. Myra Davis to serve as a member of the Board, effective October 1, 2026.
Myra Davis, 61, currently
serves as the Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital, a position she held since 2023. She has served in a variety of information services and information technology roles at Texas Children’s
Hospital since 2003, including Senior Vice President and Chief Information and Innovation Officer from 2019 to 2023 and Chief Information Officer from 2009 through 2019. In this role, Ms. Davis leads enterprise technology strategy, digital
transformation, innovation, and information services for one of the nation’s leading pediatric healthcare organizations. With more than two decades of CIO-level healthcare leadership, Ms. Davis is recognized for advancing secure, scalable
technology solutions, cultivating high-performing teams, and positioning technology as a catalyst for innovation, operational excellence, and improved care delivery. Ms. Davis also serves on the Board of Directors of Werfen, a global medical
diagnostics company, and on the Advisory Board of Healthcare Information Management Systems Society of America. Ms. Davis received a Bachelor of Science degree in Computer Information Processing from Loyola University, and a Master of Science
degree in Software Design and Development from the University of St. Thomas.
As of the date of this
Current Report on Form 8-K, Ms. Davis has not been appointed to any committee of the Board.
Upon joining the Board on October 1, 2026, Ms. Davis will be entitled to receive an annual cash retainer and annual equity grant, both of which will be based on the terms, and in the amounts, as determined in accordance with the processes described in the “Director Compensation” section of the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2026.
Upon joining the Board on October 1, 2026, Ms. Davis will be entitled to receive an annual cash retainer and annual equity grant, both of which will be based on the terms, and in the amounts, as determined in accordance with the processes described in the “Director Compensation” section of the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2026.
There are no arrangements or understandings between
Ms. Davis and any other person pursuant to which she was selected to serve as a director. There are no related-party transactions between Ms. Davis and the Company that are reportable under Item 404(a) of Regulation S-K.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
|
Exhibit
|
Description of Exhibits
|
|
| 99.1 |
Press release dated September 21, 2026.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
U.S. PHYSICAL THERAPY, INC.
|
|||||||
|
Dated: September 21, 2026
|
By:
|
/s/ NCHAHCA ETTA
|
|||||
|
Nchacha Etta
|
|||||||
|
Chief Financial Officer
|
|||||||
|
(duly authorized officer and principal financial and accounting officer)
|
|||||||
CONTACT:
U.S. Physical Therapy, Inc.
Nchacha Etta, Chief Financial Officer
email: netta@usph.com
Chris Reading, Chief Executive Officer
(713) 297-7000
Three Part Advisors
Joe Noyons
(817) 778-8424
Exhibit 99.1
U.S. Physical Therapy Announces the Appointment
of New Board Member Myra Davis
Houston, TX, September 21, 2026 – U.S. Physical
Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that its Board of Directors (the “Board”) approved the
appointment of Ms. Myra Davis to serve as a member of the Board, effective October 1, 2026.
Myra Davis currently serves as the Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital, a position she
held since 2023. She has served in a variety of information services and information technology roles at Texas Children’s Hospital since 2003, including Senior Vice President and Chief Information and Innovation Officer from 2019 to 2023 and Chief
Information Officer from 2009 through 2019. In this role, Ms. Davis leads enterprise technology strategy, digital transformation, innovation, and information services for one of the nation’s leading pediatric healthcare organizations. With more than
two decades of CIO-level healthcare leadership, Ms. Davis is recognized for advancing secure, scalable technology solutions, cultivating high-performing teams, and positioning technology as a catalyst for innovation, operational excellence, and
improved care delivery. Ms. Davis also serves on the Board of Directors of Werfen, a global medical diagnostics company, and on the Advisory Board of Healthcare Information Management Systems Society of America. Ms. Davis received a Bachelor of
Science degree in Computer Information Processing from Loyola University, and a Master of Science degree in Software Design and Development from the University of St. Thomas.
Chris Reading, Chairman of the Board, CEO and Director, stated, “Myra brings a wealth of technology experience, strategic insight and leadership
experience to our Board. We are confident her background in technology and innovation will provide valuable perspective as we continue to position our Company for long-term success. Our entire Board and executive team look forward to working with
Myra and benefiting from her experience.”
About U.S. Physical Therapy, Inc.
Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 799 outpatient physical therapy clinics in 45 states. USPH clinics provide
preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically related injuries and rehabilitation of injured workers. USPH also has an industrial injury prevention
business which provides onsite services for clients’ employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments.
More information about U.S. Physical Therapy, Inc. is available at www.usph.com. The information included on that website is not incorporated into
this press release.